Results 31 to 40 of about 48,920 (248)
Predictors of carotid artery restenosis after carotid endarterectomy
Aim. To determine predictors of carotid artery restenosis in patients after carotid endarterectomy (CEA).Material and methods. The study included 100 patients with stenosing carotid atherosclerosis who underwent CEA. We performed biochemical and clinical
E. P. Kolesova +11 more
doaj +1 more source
OBJECTIVE: To compare circulating plasma levels of immunoinflammatory markers in patients with known de novo coronary artery disease and patients with postangioplasty restenosis.
Alexandre Schaan de Quadros +6 more
doaj +1 more source
Has collateral blood flow any effect on restenosis rate? Our experience
ObjectivesRestenosis is one of the important factors affecting the effectiveness of percutaneous transluminal angioplasty and stenting in the treatment of intracranial atherosclerotic stenosis.
Yanjiang Li +5 more
doaj +1 more source
BackgroundCoronary restenosis after percutaneous coronary intervention (PCI) still remains a significant limitation of the procedure. The causative mechanisms of restenosis have not yet been fully identified.
Jeffrey J W Verschuren +9 more
doaj +1 more source
Periodontitis Is Associated With Risk of Conventional Stent Restenosis: Pilot Case-Control Study
Objectives: Percutaneous coronary angioplasty with stent implantation has been established as the main form of treatment of atherosclerosis. However, 16 to 44% of patients may evolve with stent restenosis.
Raphael Osugue +6 more
doaj +1 more source
Restenosis of Coronary Arteries in Patients with Coronavirus Infection: Case Series
Introduction. Coronavirus infection is a risk factor for vascular thrombosis. This is of particular importance for patients undergoing myocardial revascularization since this infection can be a trigger for the formation of restenosis in the area of a ...
Gulnara Batenova +8 more
doaj +1 more source
ABSTRACT Introduction/Objective Acute intracranial stenting during endovascular thrombectomy (EVT) for ischemic stroke requires intraprocedural antiplatelet therapy (APT) to maintain patency. However, the hemorrhagic risk of combining APT with intravenous thrombolysis (IVT) remains uncertain.
Aaron Rodriguez‐Calienes +75 more
wiley +1 more source
An investigation into the influence of stent strut thickness on in-stent restenosis using the finite element method [PDF]
In-stent restenosis represents the major limitation for stenting procedures. In-stent restenosis is the renarrowing o f the artery lumen within a stent predominantly due to excessive growth of neointimal hyperplasia.
Basir, Fariza Fida
core
In-Stent Ulceration: An Unusual Pathology
In-stent restenosis occurs in 10–60% of cases undergoing interventional therapy. Many mechanisms explain the reason for in-stent restenosis, but restenosis due to an ulcerated plaque is very rare and has not been well reported in the literature.
Jagadeesh Kumar Kalavakunta +2 more
doaj +1 more source
A temporally controlled drug release coating is developed for abutments using a superhydrophobic coating self‐assembled on mesoporous silica. This surface provides sequential functionality: initial contamination resistance through non‐wetting, followed by controlled drug release via wettability transition.
Zhongchao Wang +8 more
wiley +1 more source

